Haemonetics Corporation

Boston, MA Health careNAICS 621900

Self-funded health planPlan year 2025Renews January
1,273Participants-5% vs. prior year
$3.0MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#22 of 40Health care in MABy participants

Overview

Haemonetics Corporation sponsors a self-funded health plan that covered 1,273 participants in plan year 2025, down 5% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
1,273 · prior year 1,340
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Haemonetics Corporation Welfare Benefit Plan, plan 510 (1,273 participants)
Stop-loss carrier
Aetna Life Insurance Company
Broker compensation
$302K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Aetna Life Insurance CompanyMedical, Prescription drug, Stop-loss971$1.0M$108K
Unum Life Insurance Company of AmericaLife, Long-term disability1,133$674K$173K
Eyemed Vision Care-Fidelity Security Life Insurance CompanyVision783$170K$16K
Federal Insurance Company (chubb)Accidental Death and Dismemberment1,157$35K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$3.0M/ year

Estimated prescription spend: 1,273 participants × $2,371 national average per member. Usually higher once dependents are counted.

$78K–$193K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$23K–$57K
Lower-cost therapeutic alternatives$34K–$70K
Generic pricing vs. actual cost$14K–$43K
PBM contract terms$8K–$23K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Haemonetics Corporation
Sponsor EIN
04-2882273
Plan number
510
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 04-2882273 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Haemonetics Corporation Savings Plus Plan
Type
401(k) plan
Participants
2,025

About this data

Source: Haemonetics Corporation's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Haemonetics Corporation.

Request a correction · Methodology